“…S1P signaling has been known to be involved in many types of pain, e.g., inflammatory pain (Lai et al, 2008 ; Mair et al, 2011 ), postsurgical pain (Camprubí-Robles et al, 2013 ), cancer-induced bone pain (Grenald et al, 2017 ) and chemotherapy-induced neuropathic pain (Janes et al, 2014 ). However, to date, only few studies address the involvement of CLCN channels in pain initiation/modulation (Poët et al, 2006 ; Bali et al, 2013 ; Pang et al, 2016 ). The present study links the chloride channels CLCN3 and CLCN5 with the excitatory role of S1P on sensory neurons and for the first time positions CLCN5 channel, which has been well studied in Dent’s disease, an inherited renal disorder characterized by hyperphosphaturia, proteinuria, hypercalciuria and the development of kidney stones, which is often associated with mutations in the CLCN5 gene (Gunther et al, 2003 ), in the field of nociception and the pain pathway.…”